708 filings
Page 10 of 36
8-K
jcbqna0 w5jrn
18 Aug 20
Departure of Directors or Certain Officers
4:47pm
DEFA14A
q7glzy
10 Aug 20
Additional proxy soliciting materials
12:00am
8-K
0bbdgbnr6d o9d
10 Aug 20
Other Events
12:00am
8-K
m5jsa9p
29 Jul 20
Entry into a Material Definitive Agreement
9:01am
8-K
vjv3hzy cy
24 Jul 20
Other Events
9:00am
8-K
x02tnxz7vlm5f8a83h
20 Jul 20
Other Events
9:00am
8-K
coq75 hxd5elfyhka7lm
17 Jul 20
Entry into a Material Definitive Agreement
4:40pm
8-K
a457yn9 qqxn57vkf5i1
1 Jul 20
Sorrento announces selection of t-VIVA-19™ as TARGETeD protein vaccine candidate for sars-cov-2
4:38pm
8-K
2plvpj65kw3o
30 Jun 20
Changes in Registrant's Certifying Accountant
4:36pm
8-K
8wtdbd6l3
12 Jun 20
Termination of a Material Definitive Agreement
4:11pm
8-K
vsl6 or6he0
5 Jun 20
Other Events
9:31am
8-K
mxhz2vsj6 hzyix
21 May 20
Other Events
7:00am
8-K
jocppsdt1hazsk87dmmn
15 May 20
SORRENTO’S STI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates Ability To Completely Inhibit In Vitro Virus Infection In Preclinical Studies
1:52pm
424B5
wle3 r3z896dim8u1
27 Apr 20
Prospectus supplement for primary offering
4:38pm
424B5
yn1224lqyy9yo1om080f
27 Apr 20
Prospectus supplement for primary offering
4:38pm
8-K
tlr5el 6n52uc
27 Apr 20
Entry into a Material Definitive Agreement
4:37pm
8-K
t2ifyid3 7h5le6d8cy
31 Mar 20
Entry into a Material Definitive Agreement
6:03am
EFFECT
vo1ojfvik2c9u7jpq2ia
23 Mar 20
Notice of effectiveness
12:15am